2013 ICD-9-CM Diagnosis Code E942.2
Antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use
- Short description: Adv eff antilipemics.
- ICD-9-CM E942.2 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, E942.2 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
- E942.2 describes the circumstance causing an injury, not the nature of the injury.
- You are viewing the 2013 version of ICD-9-CM E942.2.
- More recent version(s) of ICD-9-CM E942.2: 2014 2015.
- No ICD-10-CM code(s) convert to ICD-9-CM E942.2
Approximate Synonyms
- 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor adverse reaction (disorder)
- Adverse effect of antihyperlipidemic
- Adverse effect of antihyperlipidemic drug
- Adverse effect of bile acid resin
- Adverse effect of fibric acid derivative
- Adverse effect of niacin
- Adverse effect of statin
- Adverse reaction to fibric acid derivative
- Adverse reaction to statin
- Bile acid resin adverse reaction
- HMG COA reductase inhibitor adverse reaction
- Lipid-lowering drug adverse reaction
- Nicotinic acid adverse reaction
E942.2 Excludes
Applies To
- Cholestyramine
- Clofibrate
- Nicotinic acid derivatives
- Sitosterols
)
